Back to search

Article

CD133 expression is associated with less DNA repair, better response to chemotherapy and survival in ER-positive/HER2-negative breast cancer

2024-03-27

Abstract excerpt

<title>Abstract</title> <p><bold>Purpose:</bold> CD133, a cancer stem cells (CSC) marker, has been reported to be associated with treatment resistance and worse survival in triple-negative breast cancer (BC). However, the clinical relevance of CD133 expression in ER-positive/HER2-negative (ER+/HER2-) BC, the most abundant subtype, remains unknown. <bold>Methods:</bold> The BC cohorts from the Molecular Taxonomy o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
21177466-3f1c-5e48-890b-24ad11923a21
DOI
10.21203/rs.3.rs-4148608/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CD133 expression is associated with less DNA repair, better response to chemotherapy and survival in ER-positive/HER2-negative breast cancerDOI 10.21203/rs.3.rs-4148608/v1
Breast cancer stem cells mediated CD8 <sup>+</sup> T cell exhaustion among different molecular subtypes of breast cancer regulated via NOTCH1/RBPJ/PD-L1 axisSemantic proximity
Cancer-Associated Stemness and Epithelial-to-Mesenchymal Transition Signatures Related to Breast Invasive Carcinoma PrognosticSemantic proximity
A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutationsSemantic proximity
Cancer stem cells and HER2 positive breast cancer: The story so farSemantic proximity
Cancer stem cells are prevalent in the basal-like 2 and mesenchymal triple-negative breast cancer subtypes in vitroSemantic proximity
Genetic profiling of different phenotypic subsets of breast cancer stem cells (BCSCs) in breast cancer patientsSemantic proximity
Enriched CD44(+)/CD24(-) population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC).Semantic proximity
Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.Semantic proximity
Unraveling breast cancer response to neoadjuvant chemotherapy through integrated genomic, transcriptomic, and circulating tumor DNA analysisSemantic proximity
Cancer stem cell markers are enriched in normal tissue adjacent to triple negative breast cancer and inversely correlated with DNA repair deficiencySemantic proximity
The transcriptional landscape of cancer stem-like cell functionality in breast cancer.Semantic proximity
CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancerSemantic proximity
Select a neighboring publication to make it the new centre.